Hyperparathyroidism/Endocrine Tumor Panel

New York
Approved


Genes

AIP, APC, CASR, CDC73, CDKN1B, CHEK2, DICER1, MEN1, PRKAR1A, PTEN, RET

Conditions

  • Hyperparathyroidism-Jaw Tumor Syndrome
  • Endocrine Tumor

Clinical Utility

  • A personal history of endocrine tumors/disorders (such as: hyperparathyroidism, pituitary adenoma, thyroid cancer, carcinoid tumors, or neuroendocrine tumors)
  • A personal history of parathyroid carcinoma
  • A personal history of multi-glandular hyperparathyroidism
  • Multiple relatives on the same side of the family diagnosed with endocrine tumors and/or hyperparathyroidism.

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis
  • Capillary Sequencing

Test Code

T828

CPT Codes*

81321x1, 81404x1, 81405x1, 81406x1

ABN Required

No

Turnaround Time**

3 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs | Extracted DNA

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.